Lacosamide Injection, Solution
Product Images NDC 69543-455

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 69543-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Virtus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical structure diagram of lacosamide, showing its molecular framework with distinct functional groups including amide, methoxy, and phenyl components.*

FDA Label Image

Figure1 (Lacosamide 02)

A bar graph showing median percentage seizure reduction from baseline comparing placebo and different doses of lacosamide in three studies. The vertical axis represents seizure reduction percentage from 0% to 45%. Each study shows higher seizure reduction in lacosamide groups compared to placebo, with dose-dependent effects and statistically significant differences indicated by asterisks.*

FDA Label Image

Figure2 (Lacosamide 03)

A line graph comparing responder rates (equal to or greater improvement) versus percent of patients for Lacosamide at doses of 200 mg/day, 400 mg/day, and 600 mg/day against placebo. The vertical axis represents responder rate from -100% (worsening) to 100% (improvement), and the horizontal axis shows percent of patients from 0 to 100. The graph includes four lines illustrating the response distribution for placebo and the three Lacosamide dosages with sample sizes noted.*

FDA Label Image

Principal Display Panel (200mg per 20mL Label)

Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous solution in a single-dose 20 mL vial. The label includes dosage instructions referencing the package insert, storage information, and manufacturer details: Gland Pharma Limited (India) and distributor Virtus Pharmaceuticals, LLC.*

FDA Label Image

Principal Display Panel (200mg per 20mL Carton)

Label for Lacosamide Injection, USP, 200 mg/20 mL (10 mg/mL), an intravenous infusion solution. The label indicates the product is for intravenous use only and includes 10 single-dose 20 mL vials. Manufactured by Gland Pharma Ltd and distributed by Virtus Pharmaceuticals, LLC. The label also references dispensing a Medication Guide to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.